Menu
  • Join
  • Login
  • Contact
 

Search abstracts


The unanticipated complexities of personalised medicine in the clinic

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: WARD, Robyn (UNSW, Prince of Wales Clinical School, Randwick nsw, Australia)
  • Abstract:

    Molecular markers are used to select individuals with a differential benefit to specific therapies. In the case of high cost therapies such as anti-EGFR antibodies, a predictive biomarker represents an opportunity to limit therapy to the subgroup of patients most likely to benefit, thus improving cost-effectiveness of the drug. These and other..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses